MedPath

EVERITT, HAZEL

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Management of Irritable Bowel Syndrome in Primary Care (MIBS Trial)

Phase 4
Completed
Conditions
Irritable Bowel Syndrome
Interventions
Drug: placebo
Behavioral: CBT website with minimal support
Behavioral: No website
Behavioral: CBT website with support
First Posted Date
2009-07-08
Last Posted Date
2021-04-30
Lead Sponsor
Hazel Everitt
Target Recruit Count
135
Registration Number
NCT00934973
Locations
🇬🇧

University of Southampton, Southampton, Hampshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath